We are live on
!
Find out more
KAM
Kazazian Asset Management Portfolio holdings
AUM
$111M
1-Year Est. Return
29.02%
This Fund
S&P 500
This Quarter
Est. Return
-4.9%
1 Year Est. Return
+29.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$123M
AUM Growth
-$7.89M
(-6%)
Cap. Flow
+$3.08M
Cap. Flow
% of AUM
2.51%
Top 10 Holdings %
Top 10 Hldgs %
74.13%
Holding
79
New
18
Increased
10
Reduced
9
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$4.58M |
| 2 |
Alibaba
BABA
|
+$4.07M |
| 3 |
AdvisorShares Pure US Cannabis ETF
MSOS
|
+$2.3M |
| 4 |
FTAI Aviation
FTAI
|
+$1.89M |
| 5 |
Baidu
BIDU
|
+$1.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$2.87M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$2.12M |
| 3 |
LegalZoom.com
LZ
|
+$1.83M |
| 4 |
Pfizer
PFE
|
+$1.58M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 32.57% |
| 2 | Consumer Discretionary | 28.58% |
| 3 | Financials | 18.83% |
| 4 | Technology | 8.32% |
| 5 | Healthcare | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
argenx
ARGX
$54.2B
| $225K | 0.18% |
+380
| New | +$240K |
|
52
iShares MSCI Mexico ETF
EWW
$1.91B
| $212K | 0.17% |
+4,168
| New | +$210K |
|
53
Novartis
NVS
$298B
| $203K | 0.17% |
+1,819
| New | +$194K |
|
|
CRON
54
Cronos Group
CRON
$1.13B
| $123K | 0.1% |
67,850
| – | – |
|
55
Aurinia Pharmaceuticals
AUPH
$2.05B
| $84K | 0.07% |
+10,450
| New | +$84.7K |
|
56
DHI Group
DHX
$165M
| $78.1K | 0.06% |
+56,200
| New | +$128K |
|
57
Geron
GERN
$949M
| $75.5K | 0.06% |
+47,500
| New | +$116K |
|
58
MacroGenics
MGNX
$260M
| $24.4K | 0.02% |
19,236
-22,800
| -54% | -$59.6K |
|
59
ALX Oncology
ALXO
$285M
| $11.8K | 0.01% |
+19,000
| New | +$22.8K |
|
|
ACLX
60
DELISTED
Arcellx
ACLX
| – | – |
-2,660
| Closed | -$204K |
|
61
ADC Therapeutics
ADCT
$142M
| – | – |
-13,300
| Closed | -$26.5K |
|
62
CALL
Alnylam Pharmaceuticals
ALNY
$29.4B
| – | – |
-1,000
| Closed | -$235K |
|
|
63
Alnylam Pharmaceuticals
ALNY
$29.4B
| – | – |
-1,140
| Closed | -$268K |
|
64
Boxlight
BOXL
$2M
| – | – |
-2,066
| Closed | -$142K |
|
|
BPMC
65
CALL
DELISTED
Blueprint Medicines
BPMC
| – | – |
-4,800
| Closed | -$419K |
|
66
C4 Therapeutics
CCCC
$410M
| – | – |
-14,250
| Closed | -$51.3K |
|
67
CALL
Cytokinetics
CYTK
$10.8B
| – | – |
-4,700
| Closed | -$221K |
|
68
Dollar General
DG
$26.8B
| – | – |
-13,510
| Closed | -$1.02M |
|
69
CALL
Exelixis
EXEL
$13.1B
| – | – |
-21,400
| Closed | -$713K |
|
70
Ford
F
$55.3B
| – | – |
-15,388
| Closed | -$152K |
|
|
71
Alphabet (Google) Class A
GOOGL
$4.33T
| – | – |
-6,385
| Closed | -$1.21M |
|
72
CALL
Immunovant
IMVT
$8.18B
| – | – |
-9,500
| Closed | -$235K |
|
73
Iovance Biotherapeutics
IOVA
$2.82B
| – | – |
-11,400
| Closed | -$84.4K |
|
74
State Street SPDR S&P Regional Banking ETF
KRE
$4.58B
| – | – |
-6,845
| Closed | -$413K |
|
75
CALL
Legend Biotech
LEGN
$4.08B
| – | – |
-7,500
| Closed | -$244K |
|
Similar funds
NIM
HCM
IWP
CD
JE
JMNC
BI
GW
Kazazian Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Kazazian Asset Management held 79 positions worth $123M, down 6% from $131M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Kazazian Asset Management's Q1 2025 filing shows 18 new, 10 increased, 9 reduced and 20 closed positions. Its largest new stake was AdvisorShares Pure US Cannabis ETF: 712,558 shares worth $1.86M. The largest sale was State Street SPDR S&P Biotech ETF, an estimated $2.87M.
By sector, the portfolio is most concentrated in Communication Services at 33% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Financials.
- Kazazian Asset Management's largest Q1 2025 buy was AdvisorShares Pure US Cannabis ETF: 712,558 shares worth $1.86M.
- Kazazian Asset Management added most to Alphabet (Google) Class C in Q1 2025, an estimated $4.58M increase.
- Kazazian Asset Management's biggest Q1 2025 reduction was LegalZoom.com, cutting an estimated $1.83M.
- Kazazian Asset Management fully exited State Street SPDR S&P Biotech ETF in Q1 2025, selling an estimated $2.87M.
- Kazazian Asset Management's ten largest holdings make up 74% of its $123M portfolio in Q1 2025.
- Kazazian Asset Management opened 18 new positions and closed 20 in Q1 2025.
- Kazazian Asset Management's portfolio value fell 6% quarter-over-quarter to $123M.
Based on Kazazian Asset Management's 13F filing for Q1 2025, filed 9 May 2025.